IBO currently public float of 4.14M.On September 30, 2024, IBO’s average trading volume was 239.24K shares.
IBO) stock’s latest price update
Impact BioMedical Inc. (AMEX: IBO)’s stock price has dropped by -17.78 in relation to previous closing price of 2.39. Nevertheless, the company has seen a loss of -15.67% in its stock price over the last five trading days. globenewswire.com reported 2024-09-26 that HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect Repelling Composition” developed within IBO’s 3F™ technology platform.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IBO’s Market Performance
The simple moving average for the past 20 days is -19.76% for IBO’s stock, with a -19.76% simple moving average for the past 200 days.
IBO Trading at -19.76% from the 50-Day Moving Average
After a stumble in the market that brought IBO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.50% of loss for the given period.
Over the last 50 days, in opposition, the stock is trading unchanged at present.
During the last 5 trading sessions, IBO remain unchanged, which changed the moving average for the period of 200-days by +2.64% in comparison to the 20-day moving average, which settled at $24.84. In addition, Impact BioMedical Inc. saw -26.68% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IBO starting from DSS, INC., who purchase 1,000 shares at the price of $2.33 back on Sep 18 ’24. After this action, DSS, INC. now owns 58,800 shares of Impact BioMedical Inc., valued at $2,330 using the latest closing price.
DSS, INC., the 10% Owner of Impact BioMedical Inc., purchase 50,000 shares at $2.69 during a trade that took place back on Sep 16 ’24, which means that DSS, INC. is holding 50,000 shares at $134,500 based on the most recent closing price.
Stock Fundamentals for IBO
Equity return is now at value -16.66, with -9.43 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.
Conclusion
To wrap up, the performance of Impact BioMedical Inc. (IBO) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
